ACPE Accredited Continuing Education for Pharmacists and Pharmacy Technicians
Naloxone: Closing the Access Gap – 1 CE – Live Webinar on November 15, 2023 8PM ET
Opioid overdose deaths in the United States have risen dramatically in the last decade, largely driven by illicit fentanyl and other synthetic opioids. Naloxone, a mu-opioid receptor antagonist, rapidly and safely reverses the effects of an opioid overdose. Increased access to naloxone has been identified by the US DHHS and the Surgeon General as a key initiative for reducing opioid overdose deaths. However, less than 1 in 10 patients who could benefit from naloxone have access to this life-saving antidote. Healthcare professionals can lead the way toward closing the naloxone access gap.
This activity provides participants with data describing opioid-related harms in the United States, discuss cutting-edge public health and pharmacy-driven initiatives for increasing access to naloxone and identify key research findings that pertain to strategies for identifying patients at risk for unintentional overdose and increasing access to life-saving harm reduction interventions.
At the conclusion of this continuing education activity, the participant will be able to:
- Describe barriers to naloxone access and alternative distribution models in the United States.
- Evaluate current strategies to expand access to naloxone, naloxone devices, and proposed alternative models.
- Develop patient care strategies for increasing access to naloxone and other harm-reduction resources
AchieveCE is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. AchieveCE is also accredited by the Florida Board of Pharmacy (provider no. 50-20641). This course is approved by CE Broker, with CE Broker No. 20-899366.
AchieveCE is designated as an Approved PACE Program Provider by the Academy of General Dentistry. The formal continuing education programs of this program provider are accepted by the AGD for Fellowship/Mastership and membership maintenance credit. Approval does not imply acceptance by a state or provincial board of dentistry or AGD endorsement. The current term of approval extends from September 1, 2022 to August 31, 2025. Provider ID# 386503.
William Eggleston, PharmD, DABATreceived his Doctor of Pharmacy degree from Wilkes University and completed a fellowship in clinical toxicology and emergency medicine at SUNY Upstate Medical University and with the Upstate New York Poison Center in Syracuse, N.Y.
Financial Support Disclosure
This activity was developed by AchieveCE free of any commercial support. William Eggleston, PharmD, DABAT has no actual or potential conflicts of interest to disclose.
Level 2. Basic Application of Skills and Concepts
1.00 Contact Hour
Mental Health Professionals
Universal Activity Number
November 15, 2023 (Wed)
8 PM Eastern Time
Activity Release Date
February 25, 2022
Activity Expiration Date
February 25, 2022
Handout Download Link(s)
Already a Member?
Requirements for Credit
Participants must correctly enter the 4-digit evaluation access code provided into the test at the conclusion of the webinar and complete an activity evaluation. Credits will be reported automatically to CPE Monitor and/or CE Broker if your license information is entered properly in your profile and if the course is completed on the same day of the webinar. If you fail to complete the attendance confirmation on the same day, please contact AchieveCE’s customer support to ensure your credits are reported.
Windows 8.1, Windows 10
Mac OS X 10.1 or higher
iOS 10+, Android 4.3+
Google Chrome, Microsoft Edge, Mozilla Firefox
Adobe Acrobat Reader
Broadband Internet Connection:
T1, Hi-speed DSL or Cable
4G cellular connection
Get Unlimited CE!
Get unlimited CE for one low annual fee.
Save time and money by becoming a member!